Glenmark Pharmaceuticals launches Type 2 diabetes drug Zita D in India

Glenmark Pharmaceuticals has launched Zita D the brand name for Teneligliptin (20mg) + Dapagliflozin (5mg/10mg) fixed dose combination in India for the treatment of Type ... Read More